Trials / Terminated
TerminatedNCT01675011
Embozene Microspheres for Uterine Fibroid Embolization (UFE)
Safety and Efficacy of Embozene Microspheres for Uterine Fibroid Embolization Compared to Embosphere for Symptomatic Relief From Uterine Fibroids
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- Female
- Age
- 30 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, prospective, multi-center study of 225 female subjects age 30-50 years with symptoms from uterine fibroids. All subjects will be followed for a total of thirty-six (36) months following uterine fibroid embolization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Embozene® Microspheres | |
| DEVICE | Embosphere® |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2012-08-29
- Last updated
- 2016-03-11
- Results posted
- 2015-02-12
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01675011. Inclusion in this directory is not an endorsement.